Discover
MBOT
Microbot Medical Inc.
1.91
2 x 1.47
2 x 2.48
bid
ask
-
0.04
2.05%
2 @ 04:00 PM
1.91 +0.00 (0.00%)
| Ytd | -4.50% | |
| 1y | -23.60% |
1.91
day range
2.04
1.60
52 week range
4.67
| Open | 1.95 | Prev Close | 1.95 | Low | 1.91 | High | 2.04 | Mkt Cap | 128.28M |
| Vol | 1.56M | Avg Vol | 1.51M | EPS | -0.26 | P/E | N/A | Forward P/E | -1.87 |
| Beta | 1.63 | Short Ratio | 2.65 | Inst. Own | 7.46% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.95 | 200-d Avg | 2.28 | 1yr Est | 7.00 |
MBOT News
benzinga.com
Microbot Medical Signs Letter With Manufacturer Sanmina To Produce Its LIBERTY Single-Use, Remotely
As momentum continues to rise in the U.S., reflected in increased accounts and usage across several
globenewswire.com
Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters i
HINGHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer an
globenewswire.com
Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System
HINGHAM, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer an
benzinga.com
Microbot Medical Inks Agreement With Lovell Government Services To Serve Federal Healthcare Systems
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascu
benzinga.com
LUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target
LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Microbot Medical (NASDAQ:MBOT) wi